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Introduction 
Vascular graft infection is a rare, but serious, com- 
plication of vascular surgery. It is a problem of pros- 
thetic grafts, although less commonly it may affect 
autologous vein grafts. The long delay between the 
time of surgery and the presentation of the infection 
makes it difficult to estimate the true incidence of 
vascular graft infection. The current incidence of 
vascular graft infection is estimated at 1-6% for all 
operations. 1 
The infection of aortic grafts is associated with con- 
siderable morbidity and mortality. The associated mor- 
tality ranges from 33 to 58%. In contrast, infrainguinal 
graft infection carries a lower mortality rate, ,-,22%, 
yet the consequences are devastating. Vascular graft 
infection may result in the loss of organ function, 
amputation, and death. In some studies the amputation 
rate following infrainguinal graft infection is as high 
as 79%. 2 
Infection of the native vessels results in weakening 
of the vessel wall and disruption of the anastomosis. 
The inflammatory process results in the precipitation 
of aneurysmal dilatation, haemorrhage and fistula for- 
mation. Death may occur due to overwhelming sepsis 
or haemorrhage. 
Microbiology 
Bacterial infection accounts for the majority of vascular 
graft infection. Less frequently fungi s'6 (Candida al- 
bicans, aspergillus), mycoplasma 7 nd mycobacterium 8 
have also been identified. In recent years, there has 
been a gradual change in infection pattern. In earlier 
studies, Staphylococcus aureus accounted for 50% of all 
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vascular graft infections. 2'3'9 More recently this in- 
cidence has diminished and Staphylococcus epidermidis 
now accounts for 60% of all graft infections. 
Vascular graft infection may be divided into early 
and late infections. 1°-12 Most vascular graft infections 
occur in the early postoperative period (<4 months). 
During this period, the most commonly identified 
pathogens include coagulase-positive S. aureus and 
Gram-negative bacteria, Escherichia coli, Proteus and 
Pseudomonas eruginosa. In the late postoperative phase 
(>4 months), the most commonly identified is co- 
agulase negative S. epidermidis, and less commonly 
fungal infections. 
The response of the host to the infective organism 
is influenced by the virulence of the organism. Early 
infections tend to present with septicaemia, wound 
infection, anastomotic bleeding, leukocytosis or the 
development of a mass at the site of implantation. 
Late infections are typically more difficult to diagnose. 
In these cases the clinical signs may vary, but are 
typically absent; a leukocytosis i frequently absent, 
but the erythrocyte sedimentation rate may be raised. 
As the infection progresses, local signs develop, in- 
cluding tenderness and erythema of the skin overlying 
the graft, a perigraft mass, or a discharging sinus. 13 
The virulence of S. aureus is associated with the 
production of enzymes which cause haemolysis and 
cell necrosis. In particular, S. aureus produces coagulase 
and a wide variety of toxic proteolyfic enzymes. This 
virulent Gram-positive cocci produces an extracellular 
glycocalyx (mucin) which promotes its adherence to 
the prosthetic graft. This "mucin" protects the organ- 
ism against antibiotics and phagocytosis. In contrast, S. 
epidermidis i  a normal skin commensal, is a coagulase- 
negative organism, is less virulent and has minimal 
capacity for invasion. This pathogen has a predilection 
for prosthetic materials, and in general requires the 
presence of a foreign body for contained growth. 14'15 
Like S. aureus, it is capable of producing a mucin 
which binds itself to the prosthetic material and has 
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a protective action by reducing the penetration of 
antibiotics and inhibiting the action of antibodies and 
phagocytes. ~6The organism induces a low grade in- 
flammatory response which over a prolonged time 
course may result in anastomotic aneurysmal and 
fistulae formation. Characteristically, S. epidermidis 
graft infections present late. In previous studies the 
mean time of presentation after surgery was 41 
months. ~0 
Gram-negative pathogens may also be highly vir- 
ulent. Aggressive tissue invasion is particularly char- 
acteristic of pseudomonas graft infections. Like S. 
aureus, Pseudomonas produces proteolytic enzymes 
(proteases) which breakdown elastin, collagen and 
fibrin leading to tissue necrosis. Typically these in- 
fections present acutely, with delayed haemorrhage 
following breakdown of the anastomosis. 
Identification of the Infective Organism 
The causative organisms of vascular graft infection 
may be difficult to identify. Standard clinical practices 
for organism isolation, such as swab cultures, are 
frequently unreliable, and despite the presence of in- 
fection, negative culture results are obtained. As- 
piration of the perigraft fluid yields leukocytes, but 
frequently no organisms. 13
The micro-organisms become entrapped in an or- 
ganised biofilm surrounding the infected graft. ~7 The 
surface biofilm is a complex structure and is composed 
of coalescing colonies of bacteria nd a fibrous poly- 
saccharide matrix (glycocalyx/slime). The sampling 
error of routine culture methods can be reduced if 
the bacterial laden biofilm is disrupted. This may be 
achieved either physically or by sonification of the 
graft, using high frequency, low energy sound waves, is 
The optimal method for identification of the infective 
organism is to culture segments of the graft and dis- 
rupted membrane in tryptic soy broth. 
An improvement in culture techniques may explain 
the recent change in the pattern of vascular graft 
infection. 
Source of Infection 
Contamination of the graft with bacteria may occur 
either during surgery, at the time of implantation, or 
in the postoperative period. Most commonly con- 
tamination of the graft occurs at the time of surgery. 3"
9,~8 In these cases the most frequent source of infection 
is from endogenous pathogens from the patient's kin. 
The organisms most frequently identified correspond 
with the abundant skin commensals, notably sta- 
phylococci. 3"4 Contamination of the graft is most likely 
following direct contact between the graft and the 
patient's kin or after excessive handling of the graft. 
Other potential sources of graft contamination at 
the time of surgery include inadequate graft ster- 
ilisation and a breakdown in surgical technique. Air- 
borne particles may be an important source of micro- 
organisms which contaminate the sterile field. 19 In 
orthopaedic theatres, stringent measures are taken to 
ensure ultraclean air circulation. The high flow rate 
laminar ventilation system was first introduced by 
Charnley in an attempt o reduce prosthesis infection 
in joint replacement surgery. Limited benefit has been 
shown in reducing the incidence of infection following 
hip replacement surgery; however, this practice is not 
undertaken i  vascular surgery. 
Haematogenous and lymphatic spread of infection 
has been implicated in the pathogenesis of graft in- 
fection, particularly in association with lower limb 
infection, skin ulceration, cellulitis and gangrene. The 
division of lymphatic channels during groin dis- 
sections may result in the spread of infection; however, 
this remains unproven. 18'2° 
Bacteria have been identified in the thrombus within 
the aneurysm sac and in the arterial wall. These are a 
further potential source of vascular graft infection; 
however, their significance is unclear. 21 
Risk Factors for Graft Infection 
Clearly patients who are at greatest risk of graft in- 
fection include those who are aged with debilitating 
disease, diabetic, uraemic, jaundiced, obese, taking 
steroids or are immunocompromised. 
The risk of prosthetic vascular graft infection is 
closely linked with the development of superficial and 
wound infections. 4'8 Consequently, the factors which 
might precipitate a wound infection, including lymph- 
ocele, seroma and haematoma formation, are all as- 
sociated with a higher rate of graft infection. The groin 
in particular poses a problem, as the area tends to be 
relatively dirty. Its close proximity to the perineum 
and the redundant folds of skin considerably increase 
the colonisation of the area with skin pathogens, and 
as a result increase the risk of wound and graft in- 
fection. 8The presence of a groin haematoma following 
preoperative f moral arteriography may contribute to 
the risk of vascular graft infection, and a benefit may 
be observed from increasing the interval between inter- 
vention in the groin and surgery. 22 Direct extension of 
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infection locally results in an increased risk of vas- 
cular graft infection in association with wound 
complications. 
The incidence of graft infection increases with emer- 
gency surgery, performed for ruptured abdominal aor- 
tic aneurysm and for acutely ischaemic limb. In 
addition early reoperation, wound and graft ex- 
ploration has also been shown to significantly increase 
graft infection rates and should be avoided whenever 
possible. 2~ Particular care is required in these cases. 
A significant factor determining the risk of graft 
infection is the choice of conduit. Vascular graft in- 
fection is predominantly limited to prosthetic grafts. 
It appears that saphenous vein has an inherent re- 
sistance to graft infection, whereas prosthetic grafts 
act as any foreign body and harbour organisms within 
the interstices of the grafts. The initiating event in 
prosthetic graft infection is bacterial adherence. The 
physical property of the graft material which in- 
fluences the risk of prosthetic graft infection is the 
relative bacterial adherence of the graft. The bacterial 
adherence of Dacron is 10 to 100 times greater than 
polytetrafluoroethylene (PTFE) and varies with bac- 
terial species; however, to date clinical trials have 
failed to demonstrate any difference in infection rates 
between Dacron and PTFE. 24 
Patients with lower limb infection, cellulitis, gan- 
grene or infected leg ulcers, are at increased risk. as 
Controversy remains as to whether the spread of 
infection is haematogenous or via the lymphatic han- 
nels. In experiments performed in animals, organisms 
injected into the hind limb of dogs have been cultured 
in the ipsilateral groin wounds .  26 Whenever possible, 
in these cases of increased risk, the use of vein as the 
bypass conduit is preferred. 
Prevention of Infection 
The methods available to prevent vascular graft in- 
fection may be considered to be preoperative, peri- 
operative and postoperative. 
There is now considerable vidence that the use 
of prophylactic antibiotics reduces the incidence of 
vascular graft infection, and their use perioperatively 
is now considered to be mandatory. 27-3° There are, 
however, no strict guidelines concerning the choice of 
antibiotic or the duration of treatment. The choice of 
antibiotic will be determined by the sensitivities of the 
organisms most frequently encountered. In general, a 
broad spectrum of antibiotic cover is required and 
should cover Gram-positive organisms, particularly S. 
aureus and S. epidermidis, and Gram-negative or- 
ganisms. Adequate cover is not achieved using single 
agents. A combination of antibiotics is usually ad- 
vocated, including third generation cephalosporins or
amoxycillin and clavulanic acid (Augmentin). These 
have particular activity against S. epidermidis and 
Gram-negative organisms. Flucloxacillin may be used 
in combination for its increased activity against sta- 
phylococci. When the resistance of organisms to anti- 
biotics is suspected, for example after prolonged 
hospital admission or in cases of reoperation, then the 
combination of vancomycin and gentamicin may be 
used. In the U.K., the commonest form of antibiotic 
prophylaxis used in vascular surgery is a systemic, 
broad spectrum cephalosporin. The third generation 
cephalosporin has significant Gram-negative and posi- 
tive activity. Specific cover against anaerobes using 
metronidazole is occasionally added. 
Antibiotic prophylaxis hould certainly commence 
prior to surgery. It is our practice to give the first dose 
prior to surgery, on induction of anaesthesia, nd to 
give antibiotic prophylaxis for three doses post- 
operatively. Several studies have now shown that three 
doses of antibiotic over 24 h is adequate and a sig- 
nificant benefit from prolonged courses of antibiotic 
has not been demonstrated. 29 In addition, the pro- 
longed administration ofantibiotics may be associated 
with the proliferation of resistant organisms. More 
recently, the use of ciprofloxacin administered orally 
has been favourably compared to a three-dose r gimen 
of systemic efuroxime. 
The influence of antibiotic impregnated and gelatin 
sealed grafts on the prevention of vascular graft in- 
fection is currently being assessed. Much of the work 
has been performed in animals, but early results from 
clinical studies are now available. Powell et aI. were 
the first to describe the technique using a collagen- 
rifampicin release system. 31 Rifampicin is a semi-syn- 
thetic derivative of rifamycin B, and is the most effect- 
ive antibiotic against both coagulase positive and 
negative staphylococci, and highly effective against 
Gram-negative micro-organisms. 
Preparation of the skin prior to surgery may reduce 
skin contamination, and hence the risk of graft in- 
fection. Preoperative cleaning with antiseptic so- 
lutions, povidone iodine or chlorhexidine prior to 
surgery is recommended; however, there is no evi- 
dence to suggest hat either solution is superior. Two 
studies have been performed examining the benefit of 
preoperative bathing in antiseptic solutions and the 
results are conflicting. 28'29 The instillation of antiseptic 
solutions into the wound prior to closure is an accepted 
practice, although there is little evidence to dem- 
onstrate any benefit. 
Hair may be removed from the operative field either 
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by shaving or by  using depi latory creams. If shaving 
is per formed then this should be done as close to the 
time of surgery as possible. Sterile plastic adhesive 
drapes are used extensively; however,  this practice 
has not been shown to reduce the incidence of wound 
infection, even when the incision crosses the groin. 32 
Clearly the most  important  considerat ion in re- 
ducing the incidence of wound infection and con- 
sequently the risk of vascular graft infection is 
meticulous urgical technique. Careful tissue handl ing 
with minimal  dissection of the lymphat ic  hannels and 
haemostasis can prevent both haematoma nd seroma 
formation. Preoperative mark ing of the long sa- 
phenous  vein reduces the incidence of skin flap nec- 
rosis caused by  undercutt ing the skin edge in search 
of the vein. I2 Surgical technique is considerably more 
effective in prevent ing haematoma formation than 
suction drainage. The routine vacuum drainage of 
groin wounds  does not appear to prevent  either 
lymphocele or wound infection. 33 A careful layered 
closure of the groin wound is advised. 
Conclusion 
Vascular graft infection is the most  feared complicat ion 
of vascular surgeons and is associated with considerable 
morbid i ty  and mortality. Improv ing  our under-  
standing of the pathogenesis of vascular graft infection 
may lead to developments  in technique, result ing in 
both the prevent ion and treatment of graft infection 
and a reduct ion in its overall incidence. The role of 
prophylact ic  antibiotics in reducing the risk of graft 
infection has already been proven,  and for patients at 
particular risk of vascular graft infection the role of 
antibiotic impregnated grafts is being investigated. 
It is currently our practice to use sparingly chlor- 
hexidine liberally appl ied directly to prosthetic grafts 
prior to wound closure, and dry  pov idone iodine spray 
to the subcutaneous layers prior to closure of the 
skin. There is, of course, no substitute for good sur- 
gical technique in minimis ing the incidence of 
complications. 
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